• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性纤毛运动障碍的临床表现:系统评价和荟萃分析。

Clinical manifestations in primary ciliary dyskinesia: systematic review and meta-analysis.

机构信息

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland Both authors contributed equally.

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

出版信息

Eur Respir J. 2016 Oct;48(4):1081-1095. doi: 10.1183/13993003.00736-2016. Epub 2016 Aug 4.

DOI:10.1183/13993003.00736-2016
PMID:27492829
Abstract

Few original studies have described the prevalence and severity of clinical symptoms of primary ciliary dyskinesia (PCD). This systematic review and meta-analysis aimed to identify all published studies on clinical manifestations of PCD patients, and to describe their prevalence and severity stratified by age and sex.We searched PubMed, Embase and Scopus for studies describing clinical symptoms of ≥10 patients with PCD. We performed meta-analyses and meta-regression to explain heterogeneity.We included 52 studies describing a total of 1970 patients (range 10-168 per study). We found a prevalence of 5% for congenital heart disease. For the rest of reported characteristics, we found considerable heterogeneity (I range 68-93.8%) when calculating the weighted mean prevalence. Even after taking into account the explanatory factors, the largest part of the between-studies variance in symptom prevalence remained unexplained for all symptoms. Sensitivity analysis including only studies with test-proven diagnosis showed similar results in prevalence and heterogeneity.Large differences in study design, selection of study populations and definition of symptoms could explain the heterogeneity in symptom prevalence. To better characterise the disease, we need larger, multicentre, multidisciplinary, prospective studies that include all age groups, use uniform diagnostics and report on all symptoms.

摘要

很少有原始研究描述原发性纤毛运动障碍(PCD)的临床症状的患病率和严重程度。本系统评价和荟萃分析旨在确定所有发表的关于 PCD 患者临床表现的研究,并按年龄和性别描述其患病率和严重程度。我们在 PubMed、Embase 和 Scopus 中搜索描述了≥10 例 PCD 患者临床症状的研究。我们进行了荟萃分析和荟萃回归分析,以解释异质性。我们纳入了 52 项研究,共描述了 1970 例患者(每项研究范围为 10-168 例)。我们发现先天性心脏病的患病率为 5%。对于其他报告的特征,我们发现计算加权平均患病率时存在相当大的异质性(I 范围为 68-93.8%)。即使考虑到解释因素,所有症状的研究间方差的大部分仍然无法解释。包括仅具有经证实诊断的研究的敏感性分析显示,患病率和异质性相似。研究设计、研究人群选择和症状定义的差异很大,可能解释了症状患病率的异质性。为了更好地描述疾病,我们需要更大、多中心、多学科、前瞻性研究,包括所有年龄组,使用统一的诊断方法并报告所有症状。

相似文献

1
Clinical manifestations in primary ciliary dyskinesia: systematic review and meta-analysis.原发性纤毛运动障碍的临床表现:系统评价和荟萃分析。
Eur Respir J. 2016 Oct;48(4):1081-1095. doi: 10.1183/13993003.00736-2016. Epub 2016 Aug 4.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
4
Non-pharmacological management of infant and young child procedural pain.婴儿和幼儿操作痛的非药物处理。
Cochrane Database Syst Rev. 2023 Jun 14;6(6):CD006275. doi: 10.1002/14651858.CD006275.pub4.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中,在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值:对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
10
Pharmacological treatments in panic disorder in adults: a network meta-analysis.成人惊恐障碍的药物治疗:网络荟萃分析。
Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3.

引用本文的文献

1
An indigenous method of high-speed video microscopy for diagnosis of primary ciliary dyskinesia in children.一种用于诊断儿童原发性纤毛运动障碍的高速视频显微镜检查的本土方法。
World J Pediatr. 2025 Jun;21(6):613-618. doi: 10.1007/s12519-025-00931-5. Epub 2025 Jun 28.
2
International consensus statement on routine blood testing in primary ciliary dyskinesia.原发性纤毛运动障碍常规血液检测国际共识声明
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.01071-2024. eCollection 2025 May.
3
Analysis of clinical and genetic features in a pediatric patient with Kartagener syndrome caused by compound heterozygous mutations in the gene: a case study and literature review.
由该基因复合杂合突变引起的小儿卡塔格内综合征患者的临床和遗传特征分析:病例研究及文献综述
Front Med (Lausanne). 2025 Mar 28;12:1513370. doi: 10.3389/fmed.2025.1513370. eCollection 2025.
4
Beyond the present: current and future perspectives on the role of infections in pediatric PCD.超越当下:感染在儿童原发性纤毛运动障碍中作用的现状与未来展望
Front Pediatr. 2025 Mar 18;13:1564156. doi: 10.3389/fped.2025.1564156. eCollection 2025.
5
[Physiotherapy in Primary Ciliary Dyskinesia].[原发性纤毛运动障碍的物理治疗]
Pneumologie. 2025 Aug;79(8):577-584. doi: 10.1055/a-2502-8151. Epub 2025 Apr 1.
6
Diagnostic Role of Immunofluorescence Analysis in Primary Ciliary Dyskinesia-Suspected Individuals.免疫荧光分析在疑似原发性纤毛运动障碍个体中的诊断作用。
J Clin Med. 2025 Mar 13;14(6):1941. doi: 10.3390/jcm14061941.
7
Genetic spectrum and genotype-phenotype correlations in DNAH5-mutated primary ciliary dyskinesia: a systematic review.DNAH5 突变所致原发性纤毛运动障碍的遗传谱及基因型-表型相关性:一项系统综述
Orphanet J Rare Dis. 2025 Mar 3;20(1):97. doi: 10.1186/s13023-025-03596-5.
8
Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review.吸入性抗生素在儿童非囊性纤维化支气管扩张症中的应用:一项综述
Antibiotics (Basel). 2025 Feb 7;14(2):165. doi: 10.3390/antibiotics14020165.
9
Active cycle of breathing technique versus oscillating positive expiratory pressure therapy: Effect on lung function in children with primary ciliary dyskinesia; A feasibility study.主动呼吸循环技术与振荡呼气末正压治疗:对原发性纤毛运动障碍儿童肺功能的影响;一项可行性研究。
Chron Respir Dis. 2025 Jan-Dec;22:14799731251314872. doi: 10.1177/14799731251314872.
10
Definition of sinonasal and otological exacerbation in patients with primary ciliary dyskinesia: an expert consensus.原发性纤毛运动障碍患者鼻旁窦和耳科病情加重的定义:专家共识
ERJ Open Res. 2024 Dec 16;10(6). doi: 10.1183/23120541.00218-2024. eCollection 2024 Nov.